{"metadata":{"topics":["Accountability","Administrative law","American political philosophy","Applied ethics","Artificial objects","Asset","Attorney's fee","Beneficial ownership","Bond (finance)","Breach of contract","British Virgin Islands","Business","Business law","Business organizations","Case law","China","Civil law (common law)","Civil law (legal system)","Civil procedure","Cognitive science","Common law","Common stock","Communication","Communication design","Companies","Company","Comparative law","Consideration","Constitutional law","Construction","Contract","Contract law","Corporate finance","Corporate governance","Corporate law","Corporate personhood","Corporation","Corporations","Court","Court orders","Courts","Covenant (law)","Crime","Criminal justice","Criminal law","Culture","Custom","Damages","Debt","Doctrines","Documents","Economic law","Economy","Economy of the United States","Enumeration","Environmental law","Equity securities","Ethical principles","Ethics","Evidence","Executive branch of the United States government","Federal government of the United States","Federal judiciary of the United States","Fee","Finance","Financial economics","Financial law","Financial markets","Financial services","Government","Government agencies","Government and personhood","Government information","Government institutions","Government of South Africa","Government of the United States","Government-related organizations","Hong Kong","Human activities","Human communication","Human rights","Injunction","Intellectual works","Interest","International law","International relations","Investment","Jargon","Joint and several liability","Judiciaries","Jurisdiction","Jurisprudence","Jury","Jury trial","Justice","Language","Law","Law and economics","Law of obligations","Law of the United States","Lawsuits","Lawyer","Legal action","Legal communication","Legal concepts","Legal disputes","Legal doctrines and principles","Legal documents","Legal ethics","Legal fictions","Legal literature","Legal organizations","Legal procedure","Legal remedy","Legal writing","Lock-up period","Love","Mail","Management","Market (economics)","Microeconomics","Money","Morality","National security","Natural resources law","Nevada","Nevada corporation","Official documents","Open government","Option (finance)","Ownership","Par value","Payment","Payments","Personality traits","Philosophical theories","Philosophy","Political charters","Political economy","Political science","Political theories","Politics","Politics of the United States","Practice of law","Principles","Privacy","Private law","Professional ethics","Property","Property law","Public administration","Public law","Public policy","Public services","Public sphere","Reason","Receipt","Registered mail","Regulation","Republic","Rights","Roman law","Rules","Securities (finance)","Securities Exchange Act of 1934","Security (finance)","Separation of powers","Service industries","Service of process","Services (economics)","Severability","Share (finance)","Shareholder","Signature","Social institutions","Social issues","Sociological theories","Sources","Sources of law","South African law","State court (United States)","Statutory law","Stock","Stock market","Stock transfer agent","Strict constructionism","Supreme court case law","Taiwan","Theories of law","Trial","Trust law","U.S. state","United Kingdom","United States","United States federal law","United States federal policy","United States law","United States public law","Urban, rural, and regional economics","Value (ethics)","Virtue","Warrant (finance)","Warranty","Winmark","Witness","Works about law","Writing","Written communication"],"person_names":["chuen","holder","lam","lam wai chuen","wai chuen","xu","xu jianping"],"vars":{"Party":{"GRANTED, PLEDGED, HYPOTHECATED, SOLD, ASSIGNED OR OTHERWISE DISPOSED OF, EXCEPT AS PERMITTED THEREBY AND IN ACCORDANCE WITH THE":"[[Party 2]]","CHINA DONGFANG HEALTHCARE GROUP INC. AND ELEGANT CAPITAL HOLDINGS LIMITED, THE SECURITIES WHICH ARE REPRESENTED BY THIS CERTIFICATE MAY NOT BE":"[[Party 1]]"}},"organization_names":["china dongfang healthcare group","china dongfang healthcare group inc.","elegant capital holdings limited","inc.","lockup period","winmark"],"agreement_id":"9c368b4063adf9ae4960885a22e392a121d6e3d440dbbbd71d9bf85ccca62086","terms":["***[Signature Page to Lock-up Agreement]***","**11,411,400**","**Amendment**","**Beneficial Ownership**","**CHINA DONGFANG HEALTHCARE GROUP INC.**","**Counterparts**","**ELEGANT CAPITAL HOLDINGS LIMITED**","**Enumeration and Headings**","**Further Assurances**","**Governing Law**","**Jurisdiction and Venue; Attorneys’ Fees**","**LOCK-UP AGREEMENT**","**Lockup**","**No Additional Fees/Payment**","**No Reliance on Advice**","**No Strict Construction**","**RECITALS**","**Remedies**","**Representations and Warranties**","**Restrictive Legend**","**Severability**","**Successors and Assigns**","**[Remainder of Page Intentionally Left Blank]**","**“Holder’s Shares.”**","“**Agreement**”","“**Common Stock**”","“**Company**”","“**Elegant Capital**”","“**Exchange**”","“**Holder**”","“**Lam**”","“**Lockup Period**”","“**Share Exchange Agreement**”","“**Shareholders**”","“**Xu**”","“Winmark”"]}}